A Review of the Benefits, Adverse Events, Drug Interactions, and ...

Roby A, Kantor BA, Anderson GD, Burstein AH. St. John's wort impact on CYP3A4
activity [Poster no. 129]. New Clinical Drug Evaluation Unit, 39th Annual Meeting, Boca
Raton, FL, June 1-4, 1999.
Royal College of General Practitioners, Office of Population Censuses and Surveys,
Department of Health and Social Security. Morbidity Statistics in General Practice, 1981-
1982, Third National Study (MBSI). National Morbidity Study, London HMSO 1986.
Ruschitzka F, Meler PJ, Turina M, Luscher IF, Nob G. Acute heart transplant rejection due
to St. John's wort [letter]. Lancet 2000;355:548.
Soldner A, Christians U, Susanto M, Wacher VJ, Silver-man JA, Benet LZ. Grapefruit
juice activates P-glycoprotein-mediated drug transport. Pharm Res, 1999; 16:478485.
United Kingdom Department of Health. Press release (2000/0121) March 1, 2000.
United Kingdom Medicines Control Agency. ADR Online Information Drug Analysis Print
(ANR101), January 1, 1999:158-159.
Vandenbogaerde AL, Delaey EM, Vantieghem AM. Cytotoxicity and antiproliferative effect
of hypericin and derivatives after photosensitization. Photochem Photo-biol
1988;67:119-125.
Vistisen K, Loft S, Ioulson HE. Cytochrome P450 1A2 activity in man measured by
caffeine metabolism: effect of smoking, broccoli and exercise. Adv Exp Med Biol
1991;283:407-411.
Wheatley D. The safety of St. John's wort. [letter] Lancet 2000;355:576.
Woetk H, Buckhard G, Grunwald J. Benefits and risk of the Hypericum extract LI160,
drug monitoring study with 3250 patients. J Geriatr Neurol 1994;7(suppl. 1):S34--S38.